2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$5.25+$0.15 (+2.92%)
Price as of Oct 02, 2026 4:10 PM EDT- $409.0MMarket Cap
- 80.85%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$5.25+$0.15 (+2.92%)
Earnings Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 18.06% | ||
12-Month Momentum | 90.63% | ||
3-Month Risk Adjusted Momentum | 100.52% | ||
12-Month Risk Adjusted Momentum | 187.67% |
True Yield
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 3.07% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -5 |